Literature DB >> 17298593

Melatonin: therapeutic and clinical utilization.

A Altun1, B Ugur-Altun.   

Abstract

Melatonin, acting through melatonin receptors, is involved in numerous physiological processes including circadian entrainment, blood pressure regulation, oncogenesis, retinal physiology, seasonal reproduction, ovarian physiology, immune function and most recently in inducing osteoblast differentiation. Moreover, melatonin was proved to be a potent-free radical scavenger and a broad-spectrum antioxidant. More research is required into the effects of therapeutically modulating the melatoninergic system on circadian haemodynamics and rhythm under varying physiopathological conditions and the possible impact on morbidity and mortality in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17298593     DOI: 10.1111/j.1742-1241.2006.01191.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  51 in total

Review 1.  Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.

Authors:  Vladimir Lerner; Chanoch Miodownik
Journal:  Curr Psychiatry Rep       Date:  2011-08       Impact factor: 5.285

2.  Which is the best choice for gastroesophageal disorders: Melatonin or proton pump inhibitors?

Authors:  Joanna Dulce Favacho de Oliveira Torres; Ricardo de Souza Pereira
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-10-06

Review 3.  Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action.

Authors:  Siddharth Sukumaran; Richard R Almon; Debra C DuBois; William J Jusko
Journal:  Adv Drug Deliv Rev       Date:  2010-06-11       Impact factor: 15.470

4.  Expression of melatonin receptors and CD4 in the ovine thymus, lymph node, spleen and liver during early pregnancy.

Authors:  Jiachen Bai; Leying Zhang; Zimo Zhao; Ning Li; Bin Wang; Ling Yang
Journal:  Immunology       Date:  2020-03-17       Impact factor: 7.397

5.  Melatonin levels in premenopausal women with fibromyalgia syndrome.

Authors:  Kazim Senel; Fatih Baygutalp; Tuba Baykal; Akin Erdal; Mahir Ugur
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

6.  Protective effects of melatonin and octreotide against radiation-induced intestinal injury.

Authors:  Cem Onal; Fazilet Kayaselcuk; Erkan Topkan; Melek Yavuz; Didem Bacanli; Aydin Yavuz
Journal:  Dig Dis Sci       Date:  2010-07-23       Impact factor: 3.199

7.  Melatonin attenuates hLRRK2-induced long-term memory deficit in a Drosophila model of Parkinson's disease.

Authors:  Dongzhi Ran; Baogang Xie; Zongjie Gan; Xicui Sun; Huaiyu Gu; Junqing Yang
Journal:  Biomed Rep       Date:  2018-07-05

8.  Melatonin protects INS-1 pancreatic β-cells from apoptosis and senescence induced by glucotoxicity and glucolipotoxicity.

Authors:  Yu Hee Lee; Hye Sook Jung; Min Jeong Kwon; Jung Eun Jang; Tae Nyun Kim; Soon Hee Lee; Mi-Kyung Kim; Jeong Hyun Park
Journal:  Islets       Date:  2020-07-16       Impact factor: 2.694

9.  Serum melatonin levels in ankylosing spondilitis: correlation with disease activity.

Authors:  Kazim Senel; Tuba Baykal; Meltem Alkan Melikoglu; Akin Erdal; Saliha Karatay; Akar Karakoc; Mahir Ugur
Journal:  Rheumatol Int       Date:  2009-10-24       Impact factor: 2.631

10.  Analysis of the mechanism by which melatonin inhibits human eosinophil peroxidase.

Authors:  T Lu; S Galijasevic; I Abdulhamid; H M Abu-Soud
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.